Realising the potential of radioligand therapy: policy solutions for the barriers to implementation across Europe

Eur J Nucl Med Mol Imaging. 2020 Jun;47(6):1335-1339. doi: 10.1007/s00259-020-04745-7.

C Merkel¹, C H Whicher², J Bomanji³, K Herrmann⁴, J Ćwikła^{5

6}, N Jervis⁷, S Wait², A Chiti^{8

9}

¹ The Health Policy Partnership, London, UK. Christine.Merkel@hpolicy.com.
² The Health Policy Partnership, London, UK.
³ Institute of Nuclear Medicine UCLH NHS Foundation Trust, London, UK.
⁴ Clinic for Nuclear Medicine, Essen University Hospital, Essen, Germany.
⁵ Department of Cardiology and Cardiac Surgery, Medical School University of Warmia and Mazury, Olsztyn, Poland.
⁶ Diagnostic and Therapy Center, Warsaw, Poland.
⁷ Neuroendocrine Cancer UK, Leamington Spa, UK.
⁸ Department of Biomedical Sciences, Humanitas University, Milan, Italy.
⁹ Unit of Nuclear Medicine, Humanitas Research Hospital, Milan, Italy.

No abstract available

Publication types